Clinical Trial Update: Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the efficacy, tolerability, and pharmacoeconomic impact of zoledronic acid in prostate cancer with bone metastases. The study, sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer with Bone Metastases

Drugs mentioned

• Zoledronic acid (Zometa) (zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prostate Cancer With Bone Metastasis | Phase 4 | Status: COMPLETED